DHBUF (Delivra Health Brands) FCF Yield %: -10.63 (As of Jul. 01, 2026)


What is Delivra Health Brands FCF Yield %?

Delivra Health Brands DHBUF FCF Yield % is -10.63 as of Jul. 01, 2026. The stock has 3 warning signs investors should review. Among 1,003 Drug Manufacturers companies, Delivra Health Brands ranks worse than 81.85% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Delivra Health Brands's Trailing 12-Month Free Cash Flow is $-0.23 Mil, and Market Cap is $2.20 Mil. Therefore, Delivra Health Brands's FCF Yield % for today is -10.63%.

The historical rank and industry rank for Delivra Health Brands's FCF Yield % or its related term are showing as below:

DHBUF' s FCF Yield % Range Over the Past 10 Years
Min: -347.27   Med: -21.55   Max: 9.3
Current: -10.63


During the past 13 years, the highest FCF Yield % of Delivra Health Brands was 9.30%. The lowest was -347.27%. And the median was -21.55%.

DHBUF's FCF Yield % is ranked worse than
81.85% of 1003 companies
in the Drug Manufacturers industry
Industry Median: 0.67 vs DHBUF: -10.63

Delivra Health Brands's FCF Margin % for the quarter that ended in Mar. 2026 was -67.66%.


Delivra Health Brands FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Delivra Health Brands FCF Yield % Related Terms


Delivra Health Brands FCF Yield % Historical Data

* Premium members only.

The historical data trend for Delivra Health Brands's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delivra Health Brands FCF Yield % Chart

Delivra Health Brands Annual Data
Trend Dec16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -36.89 -70.03 -30.04 7.06 -12.89

Delivra Health Brands Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -39.64 38.49 -15.25 13.62 -77.91

DHBUF vs ZTS, UTHR: FCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Delivra Health Brands FCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Delivra Health Brands's FCF Yield % falls into.



Delivra Health Brands FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Delivra Health Brands's FCF Yield % for the fiscal year that ended in Jun. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.552 / 4.2813309
=-12.89%

Delivra Health Brands's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.615 * 4 / 3.157462
=-77.91%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -10.63 mean?
Delivra Health Brands (DHBUF) has a FCF Yield % of -10.63 as of Jul. 01, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Delivra Health Brands and its competitors. According to the industry distribution chart, Delivra Health Brands ranks #821 out of 1003 companies in the Drug Manufacturers industry, placing it in the top 81.9%.
Is Delivra Health Brands' FCF Yield % too high?
Delivra Health Brands' current FCF Yield % is -10.63. Based on the distribution chart, Delivra Health Brands ranks #821 out of 1003 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Delivra Health Brands' FCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Delivra Health Brands ranks #821 out of 1003 companies for FCF Yield %. This places Delivra Health Brands in the lower half of its industry. The industry median FCF Yield % is 0.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,003 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Delivra Health Brands and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delivra Health Brands's current FCF Yield % is -10.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delivra Health Brands stock overvalued right now?
Based on GuruFocus' analysis, Delivra Health Brands (DHBUF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.19, compared to a current price of $0.07 — trading 62.7% below its estimated fair value. The current FCF Yield % is -10.63. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Delivra Health Brands (DHBUF), the current FCF Yield % is -10.63 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delivra Health Brands Business Description

Other Exchanges 3F0:GermanyDHB:Canada
Address 999 Canada Place, Suite 404, Vancouver, BC, CAN, V6C 3E2
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.